Canyam
AI summaries for academic research
Home
Preprint
Subscribe
Favorites
Tools
Analysis
Summary
Not logged in
Back
B
Barrie Chubb
Novo Nordisk
18
H-index
53
Paper Count
809
Citation Count
0
Related Insights
Subscribe
Published Papers
23
Publication Date
Publication Date
Impact Factor
Citations
Assessment of Carbon Emission Impact of Semaglutide in Patients with Type 2 Diabetes in the United Kingdom using an Innovative Modelling Approach
Value in Health
IF
6
2026-04-28
0
PRE
AI
Niels Lund; Andreas Rasche; Matthew Taylor; Barrie Chubb; Weiwei Xu; Loveleen Taneja; Anamaria-Vera Olivieri; Yuvraj Sharma
Share
Save
Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOW
Cardiovascular Diabetology
IF
10.6
2025-12-20
0
OA
AI
Peter Rossing; Morten Lindhardt; Christian Klyver Tikkanen; Jyothi Menon; Juliette Cattin; Barnaby Hunt; Samuel J. P. Malkin; Barrie Chubb; Tina Damgaard; Rikke Borg
Share
Save
The Value of the Guideline-Recommended Management of Type 2 Diabetes-A Novel Population-Level System Dynamics Approach
DIABETES
IF
7.5
2024-06-14
0
PRE
AI
Mcewan, Philip; Padgett, Thomas; Goulden, Scott R.; Chubb, Barrie; Mansinho, Joana N.; Ren, Hongye
Share
Save
An Indirect Treatment Comparison of the Cardiovascular Protective Effect of Semaglutide vs. Liraglutide in Subjects with Type 2 Diabetes
DIABETES
IF
7.5
2023-06-20
0
PRE
AI
Chubb, Barrie; Bog, Martin
Share
Save
Once-weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK: A long-term cost-effectiveness analysis based on SUSTAIN 11
DIABETES OBESITY & METABOLISM
IF
5.7
2022-11-02
5
OA
AI
Evans, Marc; Chubb, Barrie; Malkin, Samuel J. P.; Berry, Sasha; Lawson, Jack; Hunt, Barnaby
Share
Save
The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK
EUROPEAN JOURNAL OF HEALTH ECONOMICS
IF
3
2022-09-17
5
OA
AI
Viljoen, Adie; Chubb, Barrie; Malkin, Samuel J. P.; Berry, Sasha; Hunt, Barnaby; Bain, Stephen C.
Share
Save
Preference for Type 2 Diabetes Therapies in the United States: A Discrete Choice Experiment
ADVANCES IN THERAPY
IF
4
2022-07-07
8
OA
AI
Shubrook, Jay H.; Radin, Michael; Ali, Sarah N.; Chubb, Barrie; DiPietrantonio, Kristina; Collings, Hannah; Wyn, Robin; Smith, Martina
Share
Save
An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg
DIABETES OBESITY & METABOLISM
IF
5.7
2021-08-09
16
OA
AI
Pratley, Richard E.; Catarig, Andrei-Mircea; Lingvay, Ildiko; Viljoen, Adie; Paine, Abby; Lawson, Jack; Chubb, Barrie; Gorst-Rasmussen, Anders; Miresashvili, Nino
Share
Save
The long-term cost-effectiveness of oral semaglutide in the Netherlands based on the PIONEER 2, 3 and 4 randomized controlled trials
DIABETES RESEARCH AND CLINICAL PRACTICE
IF
7.4
2021-05-01
12
OA
AI
Malkin, Samuel J. P.; Hunt, Barnaby; Huisman, Eline L.; Grand, Tobias S.; Chubb, Barrie
Share
Save
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK
ADVANCES IN THERAPY
IF
4
2020-04-18
20
OA
AI
Johansen, Pierre; Chubb, Barrie; Hunt, Barnaby; Malkin, Samuel J. P.; Sandberg, Anna; Capehorn, Matthew
Share
Save
MODELLING CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES IN THE ERA OF CARDIOVASCULAR OUTCOMES TRIALS
VALUE IN HEALTH
IF
6
2017-10-01
0
OA
AI
McEwan, P.; Chubb, B.; Bennett, H.
Share
Save
COST-UTILITY ANALYSIS OF INSULIN DEGLUDEC VS. INSULIN GLARGINE U100 TREATMENT IN PATIENTS WITH DIABETES MELLITUS TYPE 1 AND 2 IN SERBIA
VALUE IN HEALTH
IF
6
2016-11-01
0
OA
AI
Culic, M.; Russel-Szymczyk, M.; Chubb, B.; Tikkanen, C.
Share
Save
THE COST OF NON-SEVERE HYPOGLYCAEMIA IN EUROPE
VALUE IN HEALTH
IF
6
2015-11-01
14
OA
AI
Chubb, B.; Tikkanen, C.
Share
Save
THE RELATIONSHIP BETWEEN GLUCOSE-LOWERING MEDICATIONS, ADHERENCE, AND OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES
VALUE IN HEALTH
IF
6
2015-11-01
2
PRE
AI
Piercy, J.; Milligan, G.; Davies, M. J.; Detournay, B.; Orozco Beltran, D.; Chubb, B.; Bottomley, J. M.; Nicolucci, A.; Jacob, S.
Share
Save
Hypoglycaemia in adults with insulin-treated diabetes in the UK: self-reported frequency and effects
DIABETIC MEDICINE
IF
3.4
2015-09-07
45
OA
AI
Frier, B. M.; Jensen, M. M.; Chubb, B. D.
Share
Save
Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool
DIABETIC MEDICINE
IF
3.4
2015-04-22
23
OA
AI
Parekh, W. A.; Ashley, D.; Chubb, B.; Gillies, H.; Evans, M.
Share
Save
Development and validation of a cost-utility model for Type1 diabetes mellitus
DIABETIC MEDICINE
IF
3.4
2015-02-13
9
OA
AI
Wolowacz, S.; Pearson, I.; Shannon, P.; Chubb, B.; Gundgaard, J.; Davies, M.; Briggs, A.
Share
Save
SELF-REPORTED FREQUENCY AND IMPACT OF NON-SEVERE HYPOGLYCAEMIA IN INSULIN-TREATED ADULTS IN THE UK
VALUE IN HEALTH
IF
6
2014-11-01
1
OA
AI
Chubb, B.; Jensen, M. M.; Frier, B. M.
Share
Save
Cost-effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin - from the UK health care cost perspective
DIABETES OBESITY & METABOLISM
IF
5.7
2014-01-16
38
PRE
AI
Evans, M.; Wolden, M.; Gundgaard, J.; Chubb, B.; Christensen, T.
Share
Save
COST-EFFECTIVENESS OF INSULIN DEGLUDEC COMPARED WITH INSULIN GLARGINE FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATING INSULIN THERAPY IN THE UNITED KINGDOM
VALUE IN HEALTH
IF
6
2013-11-01
0
OA
AI
Evans, M.; Chubb, B.; Christensen, T.; Gundgaard, J.; Wolden, M.
Share
Save
Research Directions
No research directions
Co-authors
Cooperation Journals
M
Melanie J. Davies
H-index: 132 · Papers: 1.6K
R
Richard E. Pratley
H-index: 121 · Papers: 712
P
Peter Rossing
H-index: 120 · Papers: 1.4K
A
Andrew Briggs
H-index: 101 · Papers: 806
I
Ildiko Lingvay
H-index: 86 · Papers: 440
View more
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Not logged in.png){kind=icon}